Regulating prices of stents: State regulators hold the key to success

Stent manufacturers say keeping an eye only on them and distributors might not help

As the Centre tries to ensure that high-end stents are available adequately and maintain the sanctity of the price order, state drug regulators have to play a key role in this.
 
Experts say the efforts of state drug regulators, to a large extent, will determine the extent of success of the government’s move.
 
Some state government regulators, such as those in Maharashtra and Gujarat, are up in the game. A chief executive officer (CEO) of a leading domestic stent manufacturer told Business Standard that the Nagpur and Pune branches of the Maharashtra Food and Drug Administration (FDA) had